查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856662

正子断层扫描（PET）市场按产品类型、应用、最终用户和技术划分－2025-2032年全球预测

Positron Emission Tomography Market by Product Type, Application, End User, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，正子断层扫描 (PET) 市场规模将达到 45.7 亿美元，复合年增长率为 6.60%。

关键市场统计数据
基准年 2024 27.4亿美元
预计年份：2025年 29.2亿美元
预测年份 2032 45.7亿美元
复合年增长率 (%) 6.60%

正子断层扫描作为一种多维成像方式，影响着医疗保健领域的临床决策和策略投资。

正子断层扫描（PET）是现代分子影像的基石，它能够提供独特的视角，深入了解支撑诊断、治疗计画和疗效监测的生理和代谢过程。本文将PET定位为一种综合技术，它不仅是一种诊断手段，更融合了硬体进步、放射化学和软体主导的分析，从而为精准医疗路径提供资讯。检测器设计、影像重建演算法和放射性示踪剂化学的进步，正将PET的临床效用从肿瘤学扩展到神经病学、循环系统以及其他新兴适应症，从而重塑治疗路径和研究重点。

探索技术、临床和商业性力量的融合，以加速PET能力的提升，拓展示踪剂产品组合，重塑服务模式。

PET领域正经历变革时期，这场变革正在重新定义临床实务、技术发展和商业模式。从类比检测器系统到全数数位化飞行时间平台的过渡，提高了灵敏度、空间解析度和定量精度，从而在不影响诊断可靠性的前提下，缩短了采集时间并降低了放射性示踪剂剂量。同时，放射化学的进步拓宽了可用示踪剂的选择范围，使其不再局限于氟代脱氧葡萄糖，而是涵盖了靶向淀粉样蛋白、 Tau、前列腺特异性膜抗原和其他分子标靶的药物，从而开闢了新的临床应用途径。

分析评估截至2025年的累积关税调整如何改变了PET设备采购、示踪剂生产经济效益和跨境供应链策略。

美国关税的累积效应（有效期至2025年）对PET供应链、采购週期和跨国合作产生了复杂的影响。影响进口扫描仪零件、检测器材料和配件的关税调整增加了某些硬体配置的到岸成本，迫使采购团队重新评估其整体拥有成本并考虑替代筹资策略。此外，放射性示踪剂生产中所使用的化学品和原料的关税影响集中式和分散式示踪剂生产的成本结构，进而影响迴旋加速器和区域生产网路的投资决策。

详细的细分洞察揭示了产品选择、临床应用、终端用户需求和技术层级如何共同决定PET的采用和营运策略。

要了解PET的动态发展，需要仔细关注产品、应用、终端用户和技术等各个方面如何相互作用，从而影响市场需求和临床效用。从产品类型来看，设备和放射性示踪剂发挥互补作用。专用PET和PET/CT扫描仪决定了影像能力和吞吐量，而FDG等放射性追踪剂则决定了诊断特异性和临床工作流程。设备选择通常需要在PET/CT系统提供的高吞吐量和整合的解剖资讯与专用PET平台提供的特殊灵敏度和工作站最佳化之间进行权衡。放射性追踪剂的可用性和物流的考虑因素可以决定成像设施网路中优先考虑的临床适应症。

区域分析描绘了基础设施、报销和研究重点如何影响美洲、欧洲、中东和非洲以及亚太地区PET的取得途径和战略机会。

PET（正子断层扫描）技术的应用和能力分布的区域动态反映了美洲、欧洲、中东和非洲以及亚太地区不同的医疗基础设施、报销机制和研究重点。在美洲，完善的三级医疗网络和整合的肿瘤诊疗路径，以及私人诊断机构和学术医疗中心的积极参与，支持了PET技术在城市中心的集中部署。报销模式和临床指南的采纳影响着肿瘤和神经病学等适应症的优先顺序，而与放射化学中心的接近性影响着示踪剂的可用性和当日检测的可能性。

竞争与合作的趋势凸显了硬体创新、放射化学实力、软体整合与服务模式如何定义PET领域的策略优势。

PET生态系内各公司之间的竞争动态取决于技术差异化、放射化学能力、整合服务以及拓展临床应用范围的策略伙伴关係。硬体供应商专注于检测器创新、与CT和MRI系统的互通性以及能够减少停机时间并优化扫描仪利用率的全生命週期服务模式。同时，放射性示踪剂製造商和放射性药局则在示踪剂的多功能性、生产可靠性和物流效率方面展开竞争，尤其是在短寿命同位素领域，因为时间和分销网络对临床操作至关重要。设备供应商和示踪剂供应商之间的合作日益普遍，从而能够提供捆绑式解决方案，简化医疗机构的采购和营运整合。

为PET产业的领导者提供一系列切实可行的策略建议，以优化技术投资、保障示踪剂供应、增强分析能力并提高营运韧性。

产业领导者若想充分利用PET日益增长的临床应用价值，应采取一系列平衡的策略行动，涵盖技术选择、营运韧性和相关人员。首先，将资本规划与临床优先事项结合，可确保资本投资与肿瘤科、神经科和循环系统科所需的吞吐量和诊断广度相符。领导者应评估数位PET和飞行时间PET技术是否具有足够的临床和工作流程优势，从而证明在高容量中心采用这些技术的合理性，同时为低容量中心保留经济高效的类比PET方案。其次，透过多元化采购、本地製造合作或管理式供应协议来保障放射性示踪剂的供应，可以降低营运风险，并支持转诊网路中服务的一致性。

透过透明的多方法调查方法，结合专家访谈、技术文献综述和比较监管分析，获得可靠的见解。

本报告的研究采用多方法结合的方式，将质性专家访谈与技术文献、监管文件和临床指引发展的二次综合分析结合。主要资料来源包括对临床医生、医学物理学家、放射化学家、医疗系统采购负责人和技术主管的结构化访谈，旨在突出技术应用驱动因素、营运限制和创新重点。二级资讯来源包括同行评审出版物、会议论文集、监管出版物和示踪剂专着，这些资料记录了检测器技术、放射性示踪剂化学和影像分析技术的进步。

总结技术进步、示踪剂扩展和策略行动，最终实现PET在医疗保健领域的永续临床整合。

这份执行概要强调，PET正处于曲折点，其发展动力源于技术进步、示踪剂组合的扩展以及不断演进的服务模式，这些因素既拓展了临床应用，也增加了运营的复杂性。硬体能力、放射化学物流、软体分析以及政策环境之间的相互作用将继续影响PET在医疗机构中的应用模式。一项强调示踪剂供应多样化、有针对性地部署技术以及投资于分析和人才培养的战略应对措施，可以帮助医疗机构在控製成本和运营风险的同时，充分发挥PET的临床应用潜力。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧应用于PET影像重建和定量分析，以提高诊断准确性
  • 新型非FDG放射性示踪剂在神经退化及肿瘤治疗的研发及临床应用
  • 扩展全身PET扫描仪以提高灵敏度并实现全面、动态的全身成像
  • PET/MRI混合系统在肿瘤学和神经病学诊断中用于多参数成像的应用日益广泛
  • 数位PET检测器技术的进步提高了扫描器的成本效益和空间解析度。
  • 结合PET诊断和标靶放射性配体治疗的新兴诊疗整合方法，用于个人化医疗
  • 引入云端基础的自动化影像处理工作流程，以简化PET资料分析和报告流程
  • 不断变化的监管和报销环境加速了新型PET药物的核准流程和市场准入。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 正子断层扫描市场（依产品类型划分）

  • 装置
    • 专用PET扫描仪
    • PET/CT扫描仪
  • 无线电示踪剂
    • FDG

9. 正子断层扫描市场（按应用领域划分）

  • 心臟病学
  • 神经病学
  • 肿瘤学

第十章 正子断层扫描市场（依最终用户划分）

  • 诊断中心
  • 医院
  • 研究所

第十一章 正子断层扫描市场（依技术分类）

  • 模拟PET
  • 数字PET
  • TOF PET

第十二章 正子断层扫描市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 正子断层扫描市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国正子断层扫描市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • United Imaging Healthcare Co., Ltd.
    • Shimadzu Corporation
    • Bruker Corporation
    • Spectrum Dynamics Medical Ltd.
    • Mediso Ltd
    • Sofie Biosciences, Inc.
Product Code: MRR-742BD5183E5A

The Positron Emission Tomography Market is projected to grow by USD 4.57 billion at a CAGR of 6.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.74 billion
Estimated Year [2025] USD 2.92 billion
Forecast Year [2032] USD 4.57 billion
CAGR (%) 6.60%

A comprehensive orientation to positron emission tomography as a multi-dimensional imaging modality shaping clinical decision-making and strategic investment across healthcare

Positron emission tomography represents a cornerstone of contemporary molecular imaging, delivering unique insights into physiological and metabolic processes that underpin diagnosis, treatment planning, and therapeutic monitoring. This introduction frames PET not merely as a diagnostic modality but as an integrative technology that converges hardware sophistication, radiochemistry, and software-driven analytics to inform precision medicine pathways. Advances in detector design, image reconstruction algorithms, and radiotracer chemistry have broadened clinical utility beyond oncology to neurology, cardiology, and emerging indications, thereby reshaping care pathways and research priorities.

As imaging departments and research institutes evaluate capital allocation and clinical workflows, PET's role in enabling targeted therapies and reducing diagnostic uncertainty has become increasingly salient. Concurrently, the ecosystem supporting PET has evolved to include service models for tracer supply, scanner-as-a-service offerings, and vendor partnerships that extend lifecycle support. This dynamic environment necessitates that stakeholders balance clinical value with operational complexity, supply chain resilience, and regulatory compliance. The following sections deploy a strategic lens to examine transformative shifts, policy impacts, segmentation-specific dynamics, regional variations, competitive behavior, and actionable recommendations that will guide healthcare providers, technology developers, and investors as they navigate the PET landscape.

An exploration of the converging technological, clinical, and commercial forces that are accelerating PET capability, expanding tracer portfolios, and reshaping service models

The PET landscape is undergoing transformative shifts that are redefining clinical practice, technology development, and commercial models. The transition from analog detector systems to fully digital and time-of-flight capable platforms has driven improvements in sensitivity, spatial resolution, and quantitative accuracy, enabling shorter acquisition times and reduced radiotracer dose without compromising diagnostic confidence. In parallel, advancements in radiochemistry have expanded the palette of available tracers beyond fluorodeoxyglucose to include agents targeting amyloid, tau, prostate-specific membrane antigen, and other molecular targets, thereby opening new clinical pathways.

Concurrently, software and artificial intelligence are layering additional value by automating image processing, enhancing lesion detection, and providing decision support that augments clinician workflows. These capabilities are increasingly integrated into vendor ecosystems, where post-processing and analytics become differentiators. Operationally, the landscape is shifting toward service-centric models, including managed tracer supply and remote system maintenance, which reduce capital barriers for smaller diagnostic centers and promote wider adoption. Regulatory harmonization and cross-border collaboration on tracer production are also evolving, with stakeholders navigating complex approval pathways to scale innovative agents. Taken together, these shifts create a more versatile and clinically potent PET environment while also raising new considerations related to access, reimbursement, and workforce readiness.

An analytical assessment of how cumulative tariff adjustments through 2025 have reshaped PET equipment sourcing, tracer production economics, and cross-border supply chain strategies

The cumulative effects of United States tariff measures enacted through 2025 have introduced a complex set of influences across PET supply chains, procurement cycles, and cross-border collaboration. Tariff adjustments that affect imported scanner components, detector materials, and accessory goods have increased landed costs for certain hardware configurations, prompting procurement teams to reassess total cost of ownership and to explore alternative sourcing strategies. In addition, tariffs on chemicals and raw materials used in radiotracer production have implications for the cost structure of centralized and decentralized tracer manufacturing, influencing decisions about in-house cyclotron investments and regional production networks.

Beyond direct cost implications, tariffs have affected strategic partnerships and vendor selection, as suppliers adjust manufacturing footprints and logistics networks to mitigate exposure. This has led some technology providers to diversify manufacturing locations and to strengthen local service capabilities in key markets to preserve competitive positioning. For clinical operations, increased costs can translate into extended equipment replacement cycles, prioritization of high-throughput clinical indications, and closer scrutiny of utilization metrics to justify capital expense. At the same time, regulatory and customs complexities introduced by tariff changes have accentuated the need for robust compliance and trade expertise within organizations that import critical components or that engage in cross-border clinical trials. In response, stakeholders are accelerating supply chain transparency initiatives, exploring nearshoring options, and engaging in collaborative purchasing arrangements to preserve access to advanced imaging capabilities under shifting trade conditions.

In-depth segmentation insights revealing how product choices, clinical applications, end-user needs, and technology tiers coalesce to determine PET adoption and operational strategy

Understanding PET dynamics requires close attention to how product, application, end user, and technology dimensions interact to shape demand and clinical utility. From a product type perspective, equipment and radiotracers serve complementary roles: dedicated PET scanners and PET/CT scanners define imaging capability and throughput, while radiotracers such as FDG determine diagnostic specificity and clinical workflows. Equipment decisions often trade off between the high throughput and integrated anatomical context provided by PET/CT systems and the specialized sensitivity and station optimization of dedicated PET platforms. Radiotracer availability and logistical considerations can dictate the clinical indications that are prioritized within a network of imaging sites.

Application segmentation reveals differing clinical drivers; cardiology prioritizes perfusion and viability assessments, neurology emphasizes neurodegenerative disease characterization and seizure localization, and oncology leverages PET for staging, therapy selection, and response assessment. These application needs translate into distinctive utilization patterns across end users: diagnostic centers focus on outpatient workflows and referral-driven imaging volumes, hospitals integrate PET into multidisciplinary care pathways and inpatient workups, and research institutes emphasize protocol flexibility and novel tracer evaluation. Technology choices intersect with these dynamics, as analog PET systems may be retained for cost-sensitive settings while digital PET and time-of-flight platforms are adopted where the clinical value of higher resolution and faster throughput justifies investment. Consequently, strategic planning must account for how product type, application, end user, and technology preferences collectively influence procurement, training, and service models across diverse care settings.

A regional analysis that maps how infrastructure, reimbursement, and research priorities in the Americas, Europe Middle East & Africa, and Asia-Pacific shape PET access and strategic opportunities

Regional dynamics in PET adoption and capability distribution reflect differences in healthcare infrastructure, reimbursement frameworks, and research emphasis that vary across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, well-developed tertiary care networks and integrated oncology pathways have supported concentrated PET deployment in urban centers, accompanied by strong involvement from private diagnostic providers and academic medical centers. Reimbursement models and clinical guideline adoption influence the prioritization of indications such as oncology and neurology, while proximity to radiochemistry hubs affects tracer availability and the viability of same-day assays.

Across Europe, Middle East & Africa, heterogeneous regulatory regimes and diverse healthcare financing models create a mosaic of PET access levels; several markets demonstrate advanced clinical integration supported by national reimbursement policies and established radiopharmacy networks, whereas others are constrained by logistical and capital limitations. In Asia-Pacific, rapid investment in healthcare infrastructure, expanding clinical trial activity, and growing incidence of oncology and neurodegenerative disease are driving the expansion of PET services, often supported by government-led initiatives and public-private partnerships that accelerate facility build-outs and tracer production. These regional differences have implications for equipment manufacturers, tracer suppliers, and service providers, each of which must tailor engagement strategies to local regulatory requirements, referral patterns, and channel structures to effectively support adoption and sustainable operations.

Competitive and collaborative company trends highlighting how hardware innovation, radiochemistry strength, software integration, and service models define strategic advantage in PET

Competitive dynamics among companies in the PET ecosystem are defined by technology differentiation, radiochemistry capabilities, integrated service offerings, and strategic partnerships that extend clinical reach. Hardware providers focus on detector innovation, interoperability with CT and MRI systems, and lifecycle service models that reduce downtime and optimize scanner utilization. At the same time, radiotracer manufacturers and radiopharmacies compete on tracer variety, production reliability, and logistics performance, particularly for short-lived isotopes where timing and distribution networks are critical to clinical operations. Collaborative arrangements between equipment vendors and tracer suppliers are increasingly common, enabling bundled solutions that simplify procurement and operational integration for healthcare providers.

Companies are also innovating in software, adding quantification tools and AI-driven workflows that improve throughput and standardize reporting. Service providers offering managed supply or scanner-as-a-service models are expanding their footprint to lower barriers for smaller centers. Strategic alliances with academic centers and participation in multicenter trials help firms validate new tracers and technologies, accelerating clinical acceptance. For buyers, these dynamics mean evaluating partners not only on product specifications but also on the strength of service networks, regulatory expertise, and the ability to support clinical validation and reimbursement pathways. As the ecosystem matures, competitive advantage increasingly accrues to organizations that can offer end-to-end solutions encompassing hardware, tracer supply, analytics, and sustained operational support.

A pragmatic set of strategic recommendations for leaders to optimize technology investments, secure tracer supply, enhance analytics, and strengthen operational resilience in PET

Industry leaders seeking to capitalize on PET's expanding clinical relevance should pursue a balanced set of strategic actions that address technology choices, operational resilience, and stakeholder engagement. First, aligning capital planning with clinical priorities ensures that equipment investments match the throughput and diagnostic breadth required by oncology, neurology, and cardiology services. Leaders should evaluate whether digital PET and time-of-flight technologies deliver sufficient clinical and workflow benefits to justify adoption in high-volume sites while maintaining cost-effective analog options for lower-volume settings. Second, securing radiotracer supply through diversified sourcing, local production partnerships, or managed supply agreements reduces operational risk and supports consistent service delivery across referral networks.

Third, investing in software and analytics that streamline image processing, reporting, and data integration will enhance clinician adoption and enable value demonstration to payers. Fourth, implementing rigorous supply chain transparency and trade compliance practices will mitigate the operational impacts of tariff and policy changes. Fifth, fostering collaborative relationships with academic centers, clinical trial consortia, and payer stakeholders can accelerate evidence generation needed for guideline inclusion and reimbursement. Finally, building workforce competencies through targeted training for technologists, physicists, and interpreting physicians ensures that organizations can extract the full clinical value of advanced PET capabilities. These recommendations, taken together, create a pragmatic roadmap for organizations to expand PET services in a sustainable and clinically impactful way.

A transparent multi-method research methodology combining expert interviews, technical literature synthesis, and regulatory comparative analysis to ensure robust insights

The research underlying this report integrates a multi-method approach that combines qualitative expert engagement with secondary synthesis of technical literature, regulatory filings, and clinical guideline developments. Primary inputs include structured interviews with clinicians, medical physicists, radiochemists, health system procurement leaders, and technology executives to surface adoption drivers, operational constraints, and innovation priorities. Secondary sources encompass peer-reviewed publications, conference proceedings, regulatory agency publications, and tracer monographs that document advances in detector technology, radiotracer chemistry, and image analysis techniques.

Analytical steps involved thematic synthesis of qualitative inputs, technology capability mapping, and cross-regional regulatory comparison to elucidate adoption patterns and strategic considerations. Attention was given to validation through triangulation across practitioner interviews, technical documentation, and published clinical evidence. Care was taken to ensure factual accuracy by referencing up-to-date regulatory guidance and peer-reviewed findings on tracer performance and detector characteristics. Ethical considerations and data provenance were observed in primary data collection, with interview subjects engaged under agreed confidentiality terms. The methodology emphasizes transparency and reproducibility, enabling decision-makers to understand the evidence base that informs the insights and recommendations presented in the report.

A conclusive synthesis that connects technological progress, tracer expansion, and strategic action to the sustainable clinical integration of PET across care settings

This executive synthesis underscores that PET is at an inflection point driven by technological refinement, broader tracer portfolios, and evolving service models that together expand clinical applications and operational complexity. The interplay between hardware capability, radiochemistry logistics, software-enabled analytics, and policy environments will continue to shape adoption patterns across care settings. Strategic responses that emphasize diversified tracer supply, targeted technology deployment, and investment in analytics and workforce development will enable providers to realize PET's clinical promise while managing cost and operational risk.

Stakeholders who integrate evidence-generation activities, such as participation in multicenter trials and local validation studies, will be better positioned to influence guideline adoption and reimbursement decisions. Furthermore, proactive supply chain and trade compliance strategies can mitigate disruption stemming from tariff and policy shifts. Ultimately, the organizations that succeed will be those that combine clinical leadership with operational agility and collaborative partnerships, translating PET's technical advances into sustainable improvements in patient care and research capability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence in PET image reconstruction and quantification to enhance diagnostic accuracy
  • 5.2. Development and clinical adoption of novel non-FDG radiotracers for neurodegenerative and oncology applications
  • 5.3. Expansion of total-body PET scanners improving sensitivity and enabling comprehensive whole-body dynamic imaging
  • 5.4. Growing adoption of hybrid PET/MRI systems for multiparametric imaging in oncology and neurology diagnostics
  • 5.5. Advancements in digital PET detector technology driving cost efficiency and higher spatial resolution in scanners
  • 5.6. Emergence of theranostic approaches combining PET diagnostics with targeted radioligand therapies for personalized medicine
  • 5.7. Implementation of cloud-based and automated image processing workflows to streamline PET data analysis and reporting
  • 5.8. Regulatory and reimbursement landscape evolution accelerating approval processes and market access for novel PET agents

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Positron Emission Tomography Market, by Product Type

  • 8.1. Equipment
    • 8.1.1. Dedicated Pet Scanners
    • 8.1.2. Pet/Ct Scanners
  • 8.2. Radiotracers
    • 8.2.1. Fdg

9. Positron Emission Tomography Market, by Application

  • 9.1. Cardiology
  • 9.2. Neurology
  • 9.3. Oncology

10. Positron Emission Tomography Market, by End User

  • 10.1. Diagnostic Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes

11. Positron Emission Tomography Market, by Technology

  • 11.1. Analog Pet
  • 11.2. Digital Pet
  • 11.3. Time-Of-Flight Pet

12. Positron Emission Tomography Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Positron Emission Tomography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Positron Emission Tomography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. GE HealthCare Technologies Inc.
    • 15.3.2. Siemens Healthineers AG
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. United Imaging Healthcare Co., Ltd.
    • 15.3.6. Shimadzu Corporation
    • 15.3.7. Bruker Corporation
    • 15.3.8. Spectrum Dynamics Medical Ltd.
    • 15.3.9. Mediso Ltd
    • 15.3.10. Sofie Biosciences, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. POSITRON EMISSION TOMOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. POSITRON EMISSION TOMOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. POSITRON EMISSION TOMOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DEDICATED PET SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PET/CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY FDG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY ANALOG PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY DIGITAL PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TIME-OF-FLIGHT PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 105. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 237. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 238. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 239. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 280. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 281. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. G7 POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 292. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 293. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 294. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 295. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. NATO POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY RADIOTRACERS, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED STATES POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. CANADA POSITRON EMISSION TOMOGRAPHY MARKET SIZE, BY PRODUCT TY